NASDAQ:CSBR

Champions Oncology, Inc Earning Date

USA |NASDAQ |USD

CSBR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 13, 2021 Oct 2021 $0.00 $-0.01 $0.00
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 13, 2021 Oct 2021 $11.55M $11.25M $10.12M

Champions Oncology, Inc's next earnings date is Monday, Dec 13, 2021 for the fiscal quarter ending Oct 2021.

CSBR Earnings Date & History Chart

CSBR Earnings & Revenue Forecast

CSBR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Oct 2021 2 $0.00 $0.00 $0.01
Jan 2022 2 $0.03 $0.03 $0.04
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2022 2 $0.06 $0.05 $0.07
Apr 2023 3 $0.24 $0.20 $0.27

CSBR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Oct 2021 0 / 0 $0.03 $0.04 $0.04
Jan 2022 0 / 0 $0.05 $0.05 $0.05
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Apr 2022 0 / 0 $0.10 $0.15 $0.16
Apr 2023 0 / 0 $0.27 $0.30 $0.00

CSBR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Oct 2021 3 $11.55M $11.32M $11.90M
Jan 2022 3 $12.52M $12.21M $12.70M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2022 3 $48.28M $47.94M $48.60M
Apr 2023 3 $56.35M $55.80M $57.39M

CSBR Earnings Date & Revenue History

CSBR Earnings History

|
Show More
Show More

CSBR Revenue History

|
Show More
Show More

Champions Oncology, Inc Next Earnings Date & Report

CSBR Next Earnings Date & Report Preview: Oct 2021 (FQ)

CSBR's next earnings date is Monday, Dec 13, 2021 for the fiscal quarter ending Oct 31, 2021.

According to 2 analysts, the average EPS estimation for Champions Oncology, Inc's next quarterly earnings is $0.00, with a low EPS estimation of $0.00, and a high estimation of $0.01.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.03, the last 2 month trend is $0.04, and the 3 month trend is $0.04.

Based on 2 analysts, the average revenue estimation is $11.55M, with a low revenue estimation of $11.32M, and a high estimation of $11.90M.

Champions Oncology, Inc Previous Earnings Dates & Reports

CSBR Previous Earnings Date & Report Recap: Jul 2021 (FQ)

Champions Oncology, Inc's previous earnings date was Sep 13, 2021 for its fiscal quarter ended Jul 31, 2021.

CSBR's earnings per share (EPS) was $-0.01, missing the consensus analysts forecast of $0.01 by -200.00%.

The EPS was higher than the previous fiscal quarter (Apr 2021) by -75.00%, and lower than the same period a year before (Jul 2020) by -200.00%.

Revenues were $11.25M, better than the forecast of $10.97M by 2.58%, up by 6.52% from the previous quarter , and up by 17.87% from the same period last year.

The company reported a net income of $-172.00K.

Free cash flow for the quarter was $-691.00K , compared to $-2.83M last quarter and $-1.43M a year before.

CSBR ended the quarter with $9.51M in total debt, a decrease of -0.99% compared to the previous quarter, and an increase of 43.36% compared to the same quarter a year before.

CSBR Previous Earnings Date & Report Recap: Apr 2021 (FY)

Champions Oncology, Inc's previous annual earnings date was Jul 22, 2021 for its fiscal year ended Apr 30, 2021.

CSBR's earnings per share (EPS) was $0.02, missing the consensus analysts forecast of $0.06 by -66.50% , and higher than the previous year's EPS (Apr 2020) by -111.17%.

Revenues were $41.04M, better than the forecast of $40.51M by 1.31%, and up by 27.76% from previous year's revenue.

The company reported a net income of $362.00K.

Champions Oncology, Inc reported a free cash flow of $-4.96M for its fiscal year, compared to $685.00K a year ago.

The company ended the fiscal year with $9.60M in total debt, an increase of 152.79% compared to the previous year.